Aluminum-associated bone disease: considerations on the pathogenesis and the effects of deferoxamine treatment.
D000535:Aluminum / Q000009:adverse effects*; D001847:Bone Diseases / Q000139:chemically induced* / Q000188:drug therapy; D002118:Calcium / Q000378:metabolism; D003676:Deferoxamine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010006:Osteoblasts / Q000187:drug effects / Q000378:metabolism; D006435:Renal Dialysis / Q000009:adverse effects
D000535:Aluminum; D003676:Deferoxamine; D002118:Calcium